Food ingredients firm Chr. Hansen has implemented bioinformatics suites from CLC Bio and Genostar as part of its in-house pipeline for analyzing next-generation sequence data.

In addition to internally developed software, the company is using several CLC Bio products, including CLC Genomics Server and CLC Genomics Workbench, to assemble its NGS data. The company is also using Genostar's Metabolic Pathway Builder and KoriBlast for "gene-oriented" analyses such as gene finding, gene annotation, comparative genomics, and metabolic mapping.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.